肿瘤基础与临床
腫瘤基礎與臨床
종류기출여림상
JOURNAL OF BASIC AND CLINICAL ONCOLOGY
2015年
4期
330-332
,共3页
周红林%姜祖光%岳文彬%刘月芬%李伟芳%李慎柯
週紅林%薑祖光%嶽文彬%劉月芬%李偉芳%李慎柯
주홍림%강조광%악문빈%류월분%리위방%리신가
原发性肝癌%经导管动脉化疗栓塞%射频消融
原髮性肝癌%經導管動脈化療栓塞%射頻消融
원발성간암%경도관동맥화료전새%사빈소융
hepatocellular carcinoma%transcatheter arterial chemoembolization%radiofrequency ablation
目的:研究经导管动脉化疗栓塞(TACE)联合射频消融(RFA)治疗原发性肝癌的临床疗效。方法79例原发性肝癌患者分为2组:TACE 联合 RFA 组38例接受 TACE 联合 RFA 治疗,而单纯 TACE 组41例仅接受 TACE 治疗。结果 TACE 联合 RFA 组总有效率高于单纯 TACE 组,差异有统计学意义( P <0.05)。TACE 联合 RFA 组1、2 a 生存率及中位生存期均高于单纯 TACE 组,差异均有统计学意义(P 均<0.05)。结论与单纯 TACE 相比,TACE 联合 RFA 方案能显著提高原发性肝癌的近远期疗效。
目的:研究經導管動脈化療栓塞(TACE)聯閤射頻消融(RFA)治療原髮性肝癌的臨床療效。方法79例原髮性肝癌患者分為2組:TACE 聯閤 RFA 組38例接受 TACE 聯閤 RFA 治療,而單純 TACE 組41例僅接受 TACE 治療。結果 TACE 聯閤 RFA 組總有效率高于單純 TACE 組,差異有統計學意義( P <0.05)。TACE 聯閤 RFA 組1、2 a 生存率及中位生存期均高于單純 TACE 組,差異均有統計學意義(P 均<0.05)。結論與單純 TACE 相比,TACE 聯閤 RFA 方案能顯著提高原髮性肝癌的近遠期療效。
목적:연구경도관동맥화료전새(TACE)연합사빈소융(RFA)치료원발성간암적림상료효。방법79례원발성간암환자분위2조:TACE 연합 RFA 조38례접수 TACE 연합 RFA 치료,이단순 TACE 조41례부접수 TACE 치료。결과 TACE 연합 RFA 조총유효솔고우단순 TACE 조,차이유통계학의의( P <0.05)。TACE 연합 RFA 조1、2 a 생존솔급중위생존기균고우단순 TACE 조,차이균유통계학의의(P 균<0.05)。결론여단순 TACE 상비,TACE 연합 RFA 방안능현저제고원발성간암적근원기료효。
Objective To study the clinical efficacy of transcatheter arterial chemoembolization(TACE)com-bined with radiofrequency ablation(RFA)in the treatment of hepatocellular carcinoma. Methods Seventy-nine patients with hepatocellular carcinoma were divided into two groups,41 patients of the TACE combined with RFA group received the TACE combined with RFA treatment,and 38 patients of the TACE group received the TACE treatment. Results The total response rate of the TACE combined with RFA group was higher than that of the TA-CE group(P < 0. 05). The 1-year survival rate,the 2-year survival rate and the median survival time of the TACE combined with RFA group were higher than those of the TACE group(P < 0. 05). Conclusion Compared with TA-CE,TACE combined with RFA can improve the efficacy on patients with hepatocellular carcinoma.